InvestorsObserver
×
News Home

Is Cleveland BioLabs, Inc. (CBLI) Stock About to Get Hot Tuesday?

Tuesday, July 14, 2020 02:49 PM | InvestorsObserver Analysts

Mentioned in this article

Is Cleveland BioLabs, Inc. (CBLI) Stock About to Get Hot Tuesday?

The market has been down on Cleveland BioLabs, Inc. (CBLI) stock recently. CBLI gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish
Cleveland BioLabs, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CBLI!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Recent trends are a good indator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.

InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.

Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CBLI Stock Today?

Cleveland BioLabs, Inc. (CBLI) stock is trading at $2.87 as of 2:48 PM on Tuesday, Jul 14, a rise of $0.79, or 37.98% from the previous closing price of $2.08. The stock has traded between $1.95 and $2.88 so far today. Volume today is below average. So far 810,546 shares have traded compared to average volume of 2,468,362 shares.

To screen for more stocks like Cleveland BioLabs, Inc. click here.

More About Cleveland BioLabs, Inc.

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App